NWRN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Newron Pharmaceuticals SpA

Watchlist Manager

Watchlist

Price: 8.07 CHF -1.34% Market Closed

Market Cap: CHf167.9m

	Newron Pharmaceuticals SpA SIX:NWRN	IT

Profitability Summary

Newron Pharmaceuticals SpA's profitability score is 54/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

95%

Declining Gross Margin

94% > 89%

Negative Operating Margin

-25%

Negative 3Y Average Operating Margin

-52%

Operating Margin is Increasing

-127% > -25%

Negative Net Margin

-69%

Negative 3Y Average Net Margin

-89%

Net Margin is Increasing

-180% > -69%

Exceptional Free Cash Flow Margin

169%

Negative 3Y Average Free Cash Flow Margin

-26%

Free Cash Flow Margin is Increasing

-127% > 169%

Exceptional ROE

274%

Exceptional 3Y Average ROE

View All

Hide

Collapse

54 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.